From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research

被引:0
|
作者
Cynthia L. Hsu
Rohit Loomba
机构
[1] University of California at San Diego,Division of Gastroenterology and Hepatology, Department of Medicine
[2] VA San Diego Healthcare System,Department of Medicine
[3] University of California at San Diego,MASLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine
[4] University of California at San Diego,The Herbert Wertheim School of Public Health and Human Longevity Science
来源
Nature Metabolism | 2024年 / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Non-alcoholic liver disease (NAFLD) is now metabolic dysfunction-associated steatotic liver disease (MASLD), emphasizing the key metabolic factors of obesity, insulin resistance, vascular dysfunction and dyslipidaemia. Here, we discuss impacts on the existing body of clinical and preclinical liver disease research and on research moving forward.
引用
收藏
页码:600 / 602
页数:2
相关论文
共 50 条
  • [1] From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research
    Hsu, Cynthia L.
    Loomba, Rohit
    NATURE METABOLISM, 2024, 6 (04) : 600 - 602
  • [2] "What's in a name?" - The implications of change in nomenclature for fatty liver disease from NAFLD to MAFLD to MASLD
    Niriella, Madunil Anuk
    CEYLON MEDICAL JOURNAL, 2023, 68 (03) : 91 - 94
  • [3] From NAFLD to MASLD: Promise and pitfalls of a new definition
    Cusi, Kenneth
    Younossi, Zobair
    Roden, Michael
    HEPATOLOGY, 2024, 79 (02) : E13 - E15
  • [4] From NAFLD to MASLD: Promise and pitfalls of a new definition
    Cusi, Kenneth
    Younossi, Zobair
    Roden, Michael
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [5] From NAFLD to MASLD: Promise and pitfalls of a new definition
    Cusi, Kenneth
    Younossi, Zobair
    Roden, Michael
    JOURNAL OF HEPATOLOGY, 2024, 81 (01) : e18 - e19
  • [6] What Is in a Name: from NAFLD to MAFLD and MASLD—Unraveling the Complexities and Implications
    Ramírez-Mejía M.M.
    Méndez-Sánchez N.
    Current Hepatology Reports, 2023, 22 (4) : 221 - 227
  • [7] Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition'
    Rinella, Mary E.
    Narro, Graciela E. Castro
    Krag, Aleksander
    Terrault, Norah
    Newsome, Philip N.
    HEPATOLOGY, 2024, 79 (02) : E16 - E17
  • [8] The transition from NAFLD to MASLD and its impact on clinical practice and outcomes
    Lu, Zhenhua
    Shao, Weiwei
    Song, Jinghai
    JOURNAL OF HEPATOLOGY, 2024, 81 (04) : e155 - e156
  • [9] Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD
    Fukunaga, Shuhei
    Mukasa, Michita
    Nakano, Dan
    Tsutsumi, Tsubasa
    Kawaguchi, Takumi
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (01)
  • [10] NAFLD: Diagnostics and New Nomenclature
    Kanagalingam, Gowthami
    Sanyal, Arun J.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (05) : 723 - 724